ε2ε2 carriers differed from ε3ε3 in having nominally lower pulse pressure and lower plasma apoB but otherwise had similar risk of IHD, similar SBP and DBP, and similar risk of type 2 diabetes and similar HbA1c (Figs. 1A and 2A). This evidence concerns the gene APOB and myocardial ischemia.